Clinical Trials Logo

Gastrointestinal Symptoms clinical trials

View clinical trials related to Gastrointestinal Symptoms.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05831527 Completed - Clinical trials for Exercise Performance

An Exploratory Investigation of a Supplement to Promote Gut Health

Start date: September 25, 2022
Phase: N/A
Study type: Interventional

Bovine colostrum is a dairy food and the first milk produced by the mother cow. Abundant research exists revealing the valuable health benefits it confers due to its unique nutritional properties., including benefits to gastrointestinal health, fitness, and overall well-being.This study aims to test a specific food-grade supplement, ARMRA Colostrum Immune Revival, over a 12-week trial to better understand the well-being, fitness, and gut benefits. This trial will use two groups, one that suffers from gastrointestinal complaints frequently and another that exercises at least three days a week.

NCT ID: NCT03959722 Completed - Clinical trials for Gastrointestinal Symptoms

The Effect of Probiotics on GI Symptoms

WHOMLF
Start date: November 19, 2019
Phase: N/A
Study type: Interventional

A double-blind randomized, placebo-controlled study will be performed with experienced endurance athletes to assess the effect of probiotics supplementation on the occurrence and intensity of the gastrointestinal symptoms, on performance and on the composition and function of the gut microbiota. The duration of the supplementation period, with Ecologic® PERFORMANCE supplements, is fourteen weeks. Standardized maximum exercise tests on a treadmill are performed before and after the supplementation period, as well as two performance tests (before) and one performance test (after). During the performance tests, the load is first submaximal for 1 hour, after which a time trial of 30 minutes will be performed. The measurements before and after the supplementation period are performed on individual days with at least 48 hours of relative rest in between. During the supplementation period, training diaries, a Profile of Mood States (POMS) questionnaire and a few questionnaires about dietary habits will be completed.

NCT ID: NCT03714464 Completed - Clinical trials for Gastrointestinal Symptoms

Effect of Physical Form of Apples on Gastrointestinal Function and Satiety: a MRI Study

Start date: February 2016
Phase: N/A
Study type: Interventional

Different physical form of apples had a significant effect on satiety and blood sugar levels which was shown in a 1977 study by Haber and his team (Haber et al.1977).It was suggested that , this effect was due to processing of the apples which modified the bioavailability of carbohydrate and fiber content.However this was not enough to explain the mechanistic effect of the apples. Within the last decade, the role of magenetic resonance imaging has been very promising in understanding gastrointestinal function and physiology. Recent MRI studies have measured changes in gastrointestinal volumes due to the effect of fermentable carbohydrates. Apple contains fermentable carbohydrates or FODMAPs. They are known to be poorly absorbed in the small and exert an osmotic effect by increasing markedly small bowel water content in the intestinal lumen as demonstrated in imaging studies.(Murray et al 2014 and Placidi et al 2012). A reduction of FODMAPs in the diet of IBS sufferers has been found to alleviate functional gut symptoms demonstrated in several randomised controlled trials. In order to fully understand the 1977 Haber study, the investigators would like to repeat the study using modern MRI methods in healthy volunteers and measure the volume changes in the stomach, small bowel and colon. In addition appetite and symptoms would also be investigated after ingesting each test meal.

NCT ID: NCT03685552 Completed - Clinical trials for Gastrointestinal Symptoms

Safety Evaluation of a Diet and Nutritional Supplementation Program- Purify 2.0

Start date: August 3, 2017
Phase: N/A
Study type: Interventional

The study evaluated the safety, tolerability and acceptability of a lifestyle modification program with nutritional supplementation designed to restore balance to healthy bowel function in generally healthy subjects

NCT ID: NCT03659747 Completed - Clinical trials for Gastrointestinal Symptoms

Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Fat-free Milk

Start date: September 11, 2018
Phase: N/A
Study type: Interventional

The main objective of the study is to investigate the effect of probiotic supplementation on lactose maldigestion.

NCT ID: NCT02277431 Completed - Abdominal Pain Clinical Trials

Probiotic Supplementation Among Adults With Recurrent Gastrointestinal Symptoms

Start date: December 2014
Phase: Phase 2/Phase 3
Study type: Interventional

Participants experiencing recurrent gastrointestinal symptoms in this double-blind, randomized, controlled trial will receive either a commercially-available probiotic dietary supplement or placebo. The investigators hypothesize that participants in the probiotic dietary supplement group will experience greater improvement in their gastrointestinal symptoms than participants in the placebo group.

NCT ID: NCT02054455 Completed - Clinical trials for Gastrointestinal Symptoms

Proton Pump Inhibitors and Gastrointestinal Symptoms

Start date: November 2012
Phase: Phase 4
Study type: Interventional

The aim of the study is to evaluate the potential protective effect of Lactobacillus paracasei subspecies paracasei F19 administration on bowel symptom onset in patients with gastro-esophageal reflux disease at long-term PPI treatment.

NCT ID: NCT01964599 Completed - Clinical trials for Gastrointestinal Symptoms

Potato Fiber and Gastrointestinal Function: Phase 3

Start date: January 2014
Phase: N/A
Study type: Interventional

The primary physiological impacts of fiber intake include the gastrointestinal effects of stool bulking, increased stool frequency and decreased gastrointestinal transit time (GTT). Fermentation of resistant starches by microbiota increases bacterial numbers, which increases fecal bulk and may impact frequency and transit time. The purpose of this study is to determine the effects of resistant potato starches (potato fiber) on stool frequency, transit time and microbiota in healthy individuals.

NCT ID: NCT01927900 Completed - Gut Microbiota Clinical Trials

The Effects Of HMO On The Faecal Microbiota And On Gastrointestinal Symptoms In Healthy Volunteers

HMO-VOL
Start date: May 2014
Phase: N/A
Study type: Interventional

The study is a randomised, placebo-controlled, double-blind, parallel, dose-finding study with healthy volunteers. A total of 100 male and female volunteers will be included. The volunteers will be randomized into one of 10 groups, each of 10 participants, consuming either active product in various mixes and doses (9 groups) or placebo product (1 group) for 2 weeks. The 9 groups receiving active product will receive either one of two Human Milk Oligosaccharides (HMOs) alone or in combination at different doses. The primary purpose of the study is establishing the effects of various compositions and doses of HMOs on the faecal flora and on gastrointestinal symptoms in health adults.

NCT ID: NCT01184456 Completed - HIV Infection Clinical Trials

A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System

Start date: August 2010
Phase: Phase 2
Study type: Interventional

Improvement in the rate of bacterial translocation may lead to a decrease in a chronic inflammatory response thereby decreasing CD4 destruction and HIV proliferation. By the addition of probiotics we hope to show a reduction in LPS leading to a decrease in chronic inflammation and therefore an improvement in immune markers.